Rong @rongl.bsky.social · 17/08/2026Check out our August digital issue here mp.weixin.qq.com/s/0677koQdmf... @natbiotech.nature.commp.weixin.qq.comNature Biotechnology八月刊内容预览 021
Rong @rongl.bsky.social · 24/07/2026New online in @natbiotech.nature.com: Spatial relationships between neoantigens and cognate T cells are studied. 022
Rong @rongl.bsky.social · 23/07/2026Check out the brief digital edition of @natbiotech.nature.com July issue here: mp.weixin.qq.com/s/mYgJDrWKRL...mp.weixin.qq.comNature Biotechnology七月刊内容预览 022
Rong @rongl.bsky.social · 03/07/2026The brief digital edition of @natbiotech.nature.com’s June issue is live now! Check it out here: mp.weixin.qq.com/s/eXJfskj-pG...mp.weixin.qq.comNature Biotechnology六月电子刊内容预览 031
Rong @rongl.bsky.social · 06/06/2026The brief digital edition of @natbiotech.nature.com’s May issue is live now! Check it out here: mp.weixin.qq.com/s/nIyLxLYlmw...mp.weixin.qq.comNature Biotechnology五月电子刊内容预览 041
Rong @rongl.bsky.social · 21/03/2026The brief digital edition of @natbiotech.nature.com’s 30th anniversary issue is live now! Check it out here: mp.weixin.qq.com/s/NklmWJ7y-H...mp.weixin.qq.comNature Biotechnology 30周年特刊内容预览 053
Reposted by RongNature Biotechnology @natbiotech.nature.com · 19/03/2026Combining optimized AAVs and enveloped delivery vehicles enable in vivo CAR‑T cell generation by integrating a CAR transgene into a T cell–specific locus. #NBThighlight www.nature.com/articles/s41...nature.comIn vivo site-specific engineering to reprogram T cells - NatureStable and cell-specific transgene expression can be achieved through in vivo site-specific integration of large DNA payloads using a two-vector system of enveloped delivery vehicles and adeno-as... 1223
Rong @rongl.bsky.social · 25/02/2026The brief digital edition of @natbiotech.nature.com’s February issue is live now! Check it out here: mp.weixin.qq.com/s/3EFLYt2JA2...mp.weixin.qq.comNature Biotechnology二月电子刊内容预览 042
Rong @rongl.bsky.social · 24/01/2026The brief digital edition of @natbiotech.nature.com’s first issue of 2026 is now live! Check it out here: mp.weixin.qq.com/s/CCnzwsGlQR...mp.weixin.qq.comNature Biotechnology 一月电子刊内容预览 031
Rong @rongl.bsky.social · 09/01/2026Our @natbiotech.nature.com editorial this month discusses how Treg cell biology research is driving therapeutic innovation in cancer immunotherapy, autoimmune diseases, and transplant rejection 030
Rong @rongl.bsky.social · 19/12/2025The brief digital edition of @natbiotech.nature.com December issue is live now! 🎉 Check it out here👉 mp.weixin.qq.com/s/s9rh4chmdT...mp.weixin.qq.comNature Biotechnology 十二月电子刊内容预览 011
Rong @rongl.bsky.social · 19/12/2025New online in @natbiotech.nature.com: Cancer immunotherapy benefits from antibody-lectin chimeras that block glyco-immune checkpoints. 031
Rong @rongl.bsky.social · 09/12/2025Our @natbiotech.nature.com editorial team picks our favorite research articles from 2025. We’ve also posted a Chinese version here 👉 mp.weixin.qq.com/s/fY10zwuljH...mp.weixin.qq.comNature Biotechnology | 2025年度关注的十大研究进展Nature Biotechnology 编辑团队精选了 2025 年度发表在 Nature Biotechn 011
Rong @rongl.bsky.social · 22/11/2025The brief digital edition of Nature Biotechnology November issue is live now! 🎉 Check it out here👉 mp.weixin.qq.com/s/RxFGoMOwgv... @natbiotech.nature.commp.weixin.qq.comNature Biotechnology 十一月电子刊内容预览 001
Rong @rongl.bsky.social · 30/10/2025Looking forward to #SITC25 next week! Please get in touch if you’d like to discuss your upcoming submissions to Nature Biotechnology! @natbiotech.nature.com 022
Rong @rongl.bsky.social · 28/10/2025New online in @natbiotech.nature.com : The interactions of CAT-T cells and solid tumors are modeled on a chip. 010
Rong @rongl.bsky.social · 28/10/2025The brief digital edition of our Nature Biotechnology October issue is live now! 🎉 Check it out here: mp.weixin.qq.com/s/nZSLSSxF4s... @natbiotech.nature.commp.weixin.qq.comNature Biotechnology 十月电子刊内容预览 021
Rong @rongl.bsky.social · 28/09/2025The brief digital edition of our @natbiotech.nature.com September issue is live now! Check it out here: mp.weixin.qq.com/s/vDXak-Ph4k...mp.weixin.qq.comNature Biotechnology 九月电子刊内容预览 001
Reposted by RongNature Biotechnology @natbiotech.nature.com · 17/09/2025On our latest podcast, Barbara Cheifet talks with Zhenan Bao and John Rogers about the latest in electronic wearables and how they will complement and advance global health — from health monitoring in neonates to smart bandages for wounds shows.acast.com/forum/episod...shows.acast.comWearables Roundtable: Bao and Rogers | Forum 012
Reposted by RongNature Biotechnology @natbiotech.nature.com · 22/08/2025Stereo-cell is a DNA nanoball array-based method that enables scalable, spatially resolved single-cell sequencing across diverse cell types and sizes with multimodal integration capabilities. #NBThighlight www.science.org/doi/10.1126/...science.orgStereo-cell: Spatial enhanced-resolution single-cell sequencing with high-density DNA nanoball-patterned arraysSingle-cell sequencing technologies have advanced our understanding of cellular heterogeneity and biological complexity. However, existing methods face limitations in throughput, capture uniformity, c... 1164
Rong @rongl.bsky.social · 14/08/2025The brief digital edition of our @natbiotech.nature.com August issue is live now! Check it out here: mp.weixin.qq.com/s/ZIDiPktIya...urldefense.comNature Biotechnology 八月电子刊内容预览 023
Rong @rongl.bsky.social · 22/06/2025The brief digital edition of our June issue is live now! Check it out here: mp.weixin.qq.com/s/S9nAe_uF0Z...mp.weixin.qq.com2025年六月电子刊内容预览 021
Reposted by RongNature Biotechnology @natbiotech.nature.com · 20/06/2025CD8-targeted lipid nanoparticles carrying anti-CD19 CAR mRNA were developed to generate CAR-T cells directly in vivo, demonstrating effective B cell depletion for potential treatment of B cell malignancies and autoimmune diseases. www.science.org/doi/10.1126/... #NBThighlightscience.orgIn vivo CAR T cell generation to treat cancer and autoimmune diseaseChimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity f... 0103
Rong @rongl.bsky.social · 22/05/2025The brief digital edition of our May issue is live now! Check it out here: mp.weixin.qq.com/s/Ph75nRcl02...mp.weixin.qq.com2025年五月电子刊内容预览 021
Reposted by RongNature Biotechnology @natbiotech.nature.com · 16/05/2025A gene-editing treatment used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases #NBTNewsBeat www.nytimes.com/2025/05/15/h...nytimes.comBaby Is Healed With World’s First Personalized Gene-Editing Treatment 1368
Reposted by RongNature Biotechnology @natbiotech.nature.com · 01/05/2025This developer of cancer immunotherapies discusses her early fascination with cellular behavior, perseverance and deep desire to directly impact patient care go.nature.com/3RSlwqL rdcu.be/ej8IOgo.nature.comFive questions with Jie Sun - Nature BiotechnologyThis developer of cancer immunotherapies discusses her early fascination with cellular behavior, perseverance and deep desire to directly impact patient care. 041
Reposted by RongNature Biotechnology @natbiotech.nature.com · 24/04/2025Cancer vaccines: the experts speak www.nature.com/articles/s41...nature.comCancer vaccines: the experts speak - Nature BiotechnologyThe development of therapeutic cancer vaccines has long been a promising yet challenging field of research. While early efforts were impeded by limited efficacy and immune escape, recent advances in i... 095
Reposted by RongNature Biotechnology @natbiotech.nature.com · 24/04/2025Synergizing advances in artificial intelligence with mathematical modeling will improve our ability to computationally predict immunotherapy outcomes go.nature.com/4jfqM3Y rdcu.be/eh1qR 083
Reposted by RongNature Biotechnology @natbiotech.nature.com · 25/04/2025Cell therapies are transforming our ability to treat cancer but are out of reach for many patients. We asked experts to share their insights into the challenges and strategies to make these therapies more broadly accessible go.nature.com/3YCJn1o rdcu.be/eiaZ4go.nature.comMaking cell therapy accessible: challenges and opportunities - Nature BiotechnologyDespite major advances in bringing cancer cell therapies to the clinic, their widespread accessibility remains a substantial challenge. High manufacturing costs, lack of funding and varying regulatory... 0135
Reposted by RongNature Biotechnology @natbiotech.nature.com · 25/04/2025The identification of novel targets together with technological advances is transforming our ability to effectively modulate the tumor microenvironment go.nature.com/42Bo9lT rdcu.be/eiiowgo.nature.comTurn cold tumors hot by reprogramming the tumor microenvironment - Nature BiotechnologyThe identification of novel targets together with technological advances is transforming our ability to effectively modulate the tumor microenvironment. 0102
Rong @rongl.bsky.social · 18/04/2025The brief digital edition of our 2025 Cancer Immunotherapy Focus Issue is live as well! Check it out here: mp.weixin.qq.com/s/i5t1sfgpL-...mp.weixin.qq.com2025年特刊--癌症免疫治疗内容预览 021
Reposted by RongIris @irismarchal.bsky.social · 16/04/2025Cell therapies are transforming our ability to treat cancer but are out of reach for many patients. @natbiotech.nature.com asked experts to share their insights into pressing challenges and promising strategies to make these therapies more broadly accessible www.nature.com/articles/s41...nature.comMaking cell therapy accessible: challenges and opportunities - Nature BiotechnologyDespite major advances in bringing cancer cell therapies to the clinic, their widespread accessibility remains a substantial challenge. High manufacturing costs, lack of funding and varying regulatory... 075
Reposted by RongIris @irismarchal.bsky.social · 15/04/2025Innate immune cells are promising candidates for cancer immunotherapy and various engineering strategies can be employed to set them up for success. Read about is in this Review in @natbiotech.nature.com and don't forget to check out our full Focus Issue! www.nature.com/articles/s41...nature.comEngineering innate immune cells for cancer immunotherapy - Nature BiotechnologyThe unique attributes of innate immune cells position them as attractive candidates for cancer immunotherapy, with engineering strategies to enhance their antitumor potential, offering notable therape... 0113
Rong @rongl.bsky.social · 15/04/2025This month, we've focused on recent developments as well as challenges in cancer immunotherapy, including cancer vaccines, immune checkpoint inhibitors, and CAR-engineered cells. Please read more👇 021
Rong @rongl.bsky.social · 15/04/2025Our 2025 Focus issue on Cancer Immunotherapy is live now! More details below 034
Reposted by RongSusan Jones @jonesysoo.bsky.social · 04/04/2025⭐ I'm hiring a new Chief editor for Nature Biomedical engineering, in New York, Beijing or Shanghai. Please apply here: springernature.wd3.myworkdayjobs.com/SpringerNatu... 045
Reposted by RongNature Biotechnology @natbiotech.nature.com · 04/04/2025Sonogenetic EchoBack-CAR T cells incorporate an ultrasensitive heat-shock promoter and synthetic positive feedback loop, enabling focused-ultrasound-controlled long-lasting CAR expression and enhanced anti-tumor efficacy. www.cell.com/cell/fulltex... #NBThighlightcell.comEngineering sonogenetic EchoBack-CAR T cellsSonogenetic EchoBack-CAR T cells were designed with an ultrasensitive heat-shock promoter screened from a library and a synthetic positive feedback loop that reprograms tumor engagement into CAR T cel... 093
Reposted by RongNature Biotechnology @natbiotech.nature.com · 02/04/2025Writing is the most essential activity of a scientist because without writing there is no thinking and no real opportunity for exchange in the marketplace of ideas go.nature.com/4iXlwRQ rdcu.be/ee4X5go.nature.comAn open letter to graduate students and other procrastinators: it’s time to write - Nature BiotechnologyNature Biotechnology - An open letter to graduate students and other procrastinators: it’s time to write 0168
Reposted by RongNature Biotechnology @natbiotech.nature.com · 01/04/20252H24 biotech job picture go.nature.com/42hUCgYgo.nature.com2H24 biotech job picture - Nature BiotechnologyA semiannual snapshot of job expansions, reductions and availability in the biotech and pharma sectors. 011
Reposted by RongNature Biotechnology @natbiotech.nature.com · 01/04/2025The lasso peptide lariocidin functions as a broad-spectrum antibiotic by binding to a unique site on the bacterial ribosome, disrupting protein synthesis without affecting human cells, and demonstrating low potential for resistance development. www.nature.com/articles/s41... #NBThighlight 0113
Rong @rongl.bsky.social · 30/03/2025The brief digital edition of our March issue is live as well! Check it out here mp.weixin.qq.com/s/5MDvA1JHC0...mp.weixin.qq.com2025年三月电子刊内容预览 031
Rong @rongl.bsky.social · 10/02/2025New online in @naturebiotech.bsky.social: Lipid nanoparticles carrying plasmid DNA and an inflammation inhibitor enable longer transgene expression than mRNA nanoparticles-by Manthan N. Patel, Jacob S. Brenner et al. 051
Rong @rongl.bsky.social · 10/02/2025New online in @naturebiotech.bsky.social: Primary T cells with multiple genetic modifications are rapidly isolated by negative selection. -by Christopher R. Chang, Brian R. Shy, Justin Eyquem et al. 011
Reposted by RongNature Biotechnology @natbiotech.nature.com · 23/01/2025A platform for the biomedical application of large language models go.nature.com/4h6FokWgo.nature.comA platform for the biomedical application of large language models - Nature BiotechnologyNature Biotechnology - A platform for the biomedical application of large language models 0144
Rong @rongl.bsky.social · 26/01/2025The brief digital edition of our @naturebiotech.bsky.social January issue is live as well! Check it out here mp.weixin.qq.com/s/GIMh7TzIzn...mp.weixin.qq.com2025年一月电子刊内容预览 010
Rong @rongl.bsky.social · 18/01/2025New online in @naturebiotech.bsky.social: A strategy for combinatorial cancer immunotherapy uses Cas13d to knock down immunosuppressive genes in vivo—by Feifei Zhang, Ryan D. Chow, Guangchuan Wang and Sidi Chen et al. 033
Reposted by RongNature Biotechnology @natbiotech.nature.com · 27/12/2024Cuba’s Center for Genetic Engineering and Biotechnology has continued to shepherd the development of drugs and vaccines for cancer, infectious disease and other conditions and to date has obtained regulatory approvals in more than 50 countries go.nature.com/4gxkhYt rdcu.be/d4Z0N 0206
Reposted by RongNature Biotechnology @natbiotech.nature.com · 23/12/2024Leveraging machine learning and big data techniques to map the global patent landscape of phage therapy go.nature.com/4iIFelb 0103
Reposted by RongNature Portfolio @natureportfolio.nature.com · 18/12/2024You also can follow Nature Portfolio editors with the starter pack we have been sharing. 13919
Rong @rongl.bsky.social · 19/12/2024New online in @naturebiotech.bsky.social: An optical pooled screening method can correlate phenotypes and perturbations in any nucleated cell type. 020
